Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Allergan, Inc.
(NY:
AGN
)
97.96
USD
+0.23 (+0.24%)
Official Closing Price
/ Updated:
6:40 PM EDT, May 23, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Allergan, Inc.
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Before the Crowd, How We Found AAPL, GOOG, AGN and MSFT
May 03, 2013
from
Marketwired News Releases
FDA Advisory Committee Unanimously Recommends JUVÉDERM VOLUMA™ XC as a Safe and Effective Treatment Option for Cheek Augmentation to Correct Age-Related Volume Deficit in the Mid-Face
May 02, 2013
from
Business Wire News Releases
Reveal Earnings Forecast for Microsoft, Apple, Advanced Micro Devices, Allergan, Freeport-McMoRan Copper & Gold, and Ford Motor
May 02, 2013
from
PR Newswire
Free Research Reports on AGN, CLD, RATE and TRLA Issued by the Bedford Report
May 02, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT
Read More
from
Marketwired News Releases
Perfect Trade Setups, How to Play AAPL, MRK, AGN and MSFT
May 02, 2013
from
Marketwired News Releases
Allergan Reports First Quarter 2013 Operating Results
May 01, 2013
from
Business Wire News Releases
Allergan Announces Death of Stephen J. Ryan, M.D.
April 30, 2013
from
Business Wire News Releases
Free Research Reports on AGN, CDE, CMA and HTZ Issued by the Paragon Report
April 17, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit
Read More
from
Marketwired News Releases
Allergan Receives Complete Response Letter from the U.S. Food and Drug Administration for LEVADEX® (dihydroergotamine) New Drug Application
April 16, 2013
from
Business Wire News Releases
Stock Alerts For Sina, SAP, Staples, Allergan, and Yelp Released By InvestorsObserver
April 08, 2013
from
PR Newswire
Allergan Announces Quarterly Conference Call
April 03, 2013
from
Business Wire News Releases
Aegean Announces Non Brokered Private Placement
April 01, 2013
from
Marketwired
Today's Analysis on Bristol-Myers Squibb, Eli Lilly & Co., Endo Pharma, and Allergan
March 28, 2013
from
PR Newswire
Aegean Appoints Eric Roth as President and CEO
March 27, 2013
from
Marketwired
The Real Story Behind SLCA, MRVL, AGN and ORLY
March 15, 2013
from
Marketwired News Releases
Clearside Biomedical, Inc. Names Stephen H. Lang Vice President, Commercial Operations
March 04, 2013
from
Business Wire News Releases
Allergan, Inc. Announces Expiration of Tender Offer for All Outstanding Shares of MAP Pharmaceuticals, Inc. and Intent to Exercise Top-Up Option to Effect a Short-Form Merger
March 01, 2013
from
Business Wire News Releases
Allergan and Endo Pharma Under StockCall's Microscope: Drug Companies Restructure Their Businesses
February 25, 2013
from
PR Newswire
FDA Approves Natrelle® 410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast Implants
February 20, 2013
from
Business Wire News Releases
Allergan, Inc. and MAP Pharmaceuticals, Inc. Announce the Federal Trade Commission Has Granted Early Termination of Waiting Period Under Hart-Scott-Rodino Act
February 07, 2013
from
Business Wire News Releases
Allergan Reports Fourth Quarter 2012 Operating Results
February 05, 2013
from
Business Wire News Releases
Free Research Report on Comcast Corp., Crown Castle International Corp., Allergan, Inc. and TD AmeriTrade Holding Corp.
February 04, 2013
from
Marketwired News Releases
Pharmaceutical Company Achieves Positive In-Vitro Testing Results Diabetes Drug
January 31, 2013
Global Pharmaceutical & Biotechnology Outlook for 2013 Continues to be Encouraging
Read More
from
PR Newswire
Allergan Commences Cash Tender Offer for All Outstanding Shares of MAP Pharmaceuticals
January 31, 2013
from
Business Wire News Releases
Faruqi & Faruqi, LLP is Seeking More Cash for the Shareholders of MAP Pharmaceuticals, Inc. (MAPP)
January 30, 2013
from
Business Wire News Releases
Not Your Traditional Gulf Coast: Texas, Louisiana Home to $1.5 Billion in Life Science Project Investment, an Industrial Info News Alert
January 30, 2013
from
Marketwired News Releases
Mergers and Acquisitions Remain Key in Big Pharma's 2013 Playbook, an Industrial Info News Alert
January 28, 2013
from
Marketwired News Releases
The Law Firm of Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by the Board of MAP Pharmaceuticals Inc. in Connection with the Sale of the Company to Allergan Inc.
January 25, 2013
from
PR Newswire
The Law Firm of Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by the Board of MAP Pharmaceuticals Inc. in Connection with the Sale of the Company to Allergan Inc.
January 24, 2013
from
Business Wire News Releases
Faruqi & Faruqi, LLP Is Seeking More Cash For The Shareholders Of MAP Pharmaceuticals, Inc. (MAPP)
January 23, 2013
from
Business Wire News Releases
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here